Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-FR
Language French French
Date Updated 2025-04-10 2025-03-20
Drug Identification Number 02408058 02408058
Brand name FENTORA FENTORA
Common or Proper name FENTORA 800MCG FENTORA 800MCG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients FENTANYL FENTANYL
Strength(s) 800MCG 800MCG
Dosage form(s) TABLET (EFFERVESCENT) TABLET (EFFERVESCENT)
Route of administration SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 28 28
ATC code N02AB N02AB
ATC description OPIOIDS OPIOIDS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2025-04-01 2025-04-01
Actual start date 2025-03-20 2025-03-20
Estimated end date 2025-06-10 2025-04-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments This is only a possible short term shortage at this time. This is only a possible short term shortage at this time.
Health Canada comments